#BEGIN_DRUGCARD DB04063

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C7H15NO2

# Chemical_IUPAC_Name:
(2S)-2-amino-2,4-dimethylpentanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-Methylleucine

# HET_ID:
2ML

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H15NO2/c1-5(2)4-7(3,8)6(9)10/h5H,4,8H2,1-3H3,(H,9,10)/t7-/m0/s1

# InChI_Key:
InChIKey=ARSWQPLPYROOBG-ZETCQYMHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4063

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
145.1995

# Molecular_Weight_Mono:
145.110278729

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1I1L

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.4

# Predicted_LogS:
-0.69

# Predicted_Water_Solubility:
2.98e+01 g/l

# Primary_Accession_No:
DB04063

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
446181

# PubChem_Substance_ID:
46508534

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00130

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C)C[C@](C)(N)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:54 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X02413

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ilvE

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
1379743	Daniels DL, Plunkett G 3rd, Burland V, Blattner FR: Analysis of the Escherichia coli genome: DNA sequence of the region from 84.5 to 86.5 minutes. Science. 1992 Aug 7;257(5071):771-8.
1569580	Pagel JM, Winkelman JW, Adams CW, Hatfield GW: DNA topology-mediated regulation of transcription initiation from the tandem promoters of the ilvGMEDA operon of Escherichia coli. J Mol Biol. 1992 Apr 20;224(4):919-35.
3069843	Inoue K, Kuramitsu S, Aki K, Watanabe Y, Takagi T, Nishigai M, Ikai A, Kagamiyama H: Branched-chain amino acid aminotransferase of Escherichia coli: overproduction and properties. J Biochem (Tokyo). 1988 Nov;104(5):777-84.
3550695	Lawther RP, Wek RC, Lopes JM, Pereira R, Taillon BE, Hatfield GW: The complete nucleotide sequence of the ilvGMEDA operon of Escherichia coli K-12. Nucleic Acids Res. 1987 Mar 11;15(5):2137-55.
3897211	Kuramitsu S, Ogawa T, Ogawa H, Kagamiyama H: Branched-chain amino acid aminotransferase of Escherichia coli: nucleotide sequence of the ilvE gene and the deduced amino acid sequence. J Biochem (Tokyo). 1985 Apr;97(4):993-9.
392469	Lawther RP, Nichols B, Zurawski G, Hatfield GW: The nucleotide sequence preceding and including the beginning of the ilvE gene of the ilvGEDA operon of Escherichia coli K12. Nucleic Acids Res. 1979 Dec 20;7(8):2289-301.
9163511	Okada K, Hirotsu K, Sato M, Hayashi H, Kagamiyama H: Three-dimensional structure of Escherichia coli branched-chain amino acid aminotransferase at 2.5 A resolution. J Biochem (Tokyo). 1997 Apr;121(4):637-41.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3688

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34094

# Drug_Target_1_Name:
Branched-chain-amino-acid aminotransferase

# Drug_Target_1_Number_of_Residues:
309

# Drug_Target_1_PDB_ID:
1IYE

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01063	Aminotran_4

# Drug_Target_1_Protein_Sequence:
>Branched-chain-amino-acid aminotransferase
MTTKKADYIWFNGEMVRWEDAKVHVMSHALHYGTSVFEGIRCYDSHKGPVVFRHREHMQR
LHDSAKIYRFPVSQSIDELMEACRDVIRKNNLTSAYIRPLIFVGDVGMGVNPPAGYSTDV
IIAAFPWGAYLGAEALEQGIDAMVSSWNRAAPNTIPTAAKAGGNYLSSLLVGSEARRHGY
QEGIALDVNGYISEGAGENLFEVKDGVLFTPPFTSSALPGITRDAIIKLAKELGIEVREQ
VLSRESLYLADEVFMSGTAAEITPVRSVDGIQVGEGRCGPVTKRIQQAFFGLFTGETEDK
WGWLDQVNQ

# Drug_Target_1_Reaction:
L-leucine + 2-oxoglutarate = 4-methyl-2-oxopentanoate + L-glutamate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Acts on leucine, isoleucine and valine

# Drug_Target_1_SwissProt_ID:
P0AB80

# Drug_Target_1_SwissProt_Name:
ILVE_ECOLI

# Drug_Target_1_Synonyms:
BCAT
EC 2.6.1.42
Transaminase B

# Drug_Target_1_Theoretical_pI:
5.62

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04063
